Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage-Reference-Cited by-同舟云学术

Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage

Published:2016-09-06 Issue:4 Volume:12 Page:2477-2488
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:en
Short-container-title:

Author:

Li Feng-Sen,Zhang Yan-Li,Li Zheng,Xu Dan,Liao Chun-Yan,Ma Huan,Gong Li,Su Jun,Sun Qi,Xu Qian,Gao Zhen,Wang Ling,Jing Jing,Wang Jing,Jiang Min,Tian Ge,Hasan Bilal

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Yiqigubiao pill treatment regulates Sirtuin 5 expression and mitochondrial function in chronic obstructive pulmonary disease;Journal of Thoracic Disease;2024-04

2. Characteristics of Serum Autoantibody Repertoire and Immune Subgroup Variation of Tuberculosis-Associated Obstructive Pulmonary Disease;International Journal of Chronic Obstructive Pulmonary Disease;2023-12

3. Yinyanghuo (Herba Epimedii Brevicornus) and its components for chronic obstructive pulmonary disease: preclinical evidence and possible mechanisms;J TRADIT CHIN MED;2023

4. Associations of Chinese Herbal Medicine Use with the Risks of Acute Exacerbation and Mortality in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study;Journal of Integrative and Complementary Medicine;2022-01-01

5. The Clinical Efficiency and the Mechanism of Sanzi Yangqin Decoction for Chronic Obstructive Pulmonary Disease;Evidence-Based Complementary and Alternative Medicine;2021-06-10